Contraindications of Ambien (Zolpidem)
Zolpidem (Ambien) is absolutely contraindicated in patients who have experienced complex sleep behaviors after taking zolpidem and in patients with known hypersensitivity to zolpidem. 1
Absolute Contraindications
- History of complex sleep behaviors: Sleep-walking, sleep-driving, or engaging in other activities while not fully awake after taking zolpidem 1
- Hypersensitivity reactions: Including anaphylaxis and angioedema 1
Relative Contraindications and Precautions
High-Risk Patient Populations
- Elderly patients: Increased risk of falls due to drowsiness and decreased level of consciousness 1
- Hepatic impairment: Reduced dosage (5 mg) recommended due to decreased clearance 2
- Respiratory conditions: Not recommended in patients with compromised respiratory function (e.g., asthma, COPD, sleep apnea) 2
- Pregnancy and nursing: Not recommended during pregnancy or breastfeeding 2
Psychiatric and Neurological Considerations
- Primary psychiatric disorders: Should be evaluated for underlying psychiatric conditions if insomnia persists beyond 7-10 days of treatment 1
- History of substance abuse: Zolpidem has potential for abuse, though lower than benzodiazepines 3
- Depression: Caution in patients with signs/symptoms of depression 2
Drug Interactions
- CNS depressants: Increased risk with concomitant use of other CNS depressants 1:
- Benzodiazepines
- Opioids
- Tricyclic antidepressants
- Alcohol
- Monoamine oxidase inhibitors (MAOIs): Contraindicated for use in combination 4
Special Warnings
Complex Sleep Behaviors
- Complex sleep behaviors may occur following the first or any subsequent use of zolpidem 1
- These behaviors can result in serious injuries or death 1
- Patients usually do not remember these events 1
- May occur with zolpidem alone at recommended doses, with or without alcohol or other CNS depressants 1
Next-Day Impairment
- Increased risk of next-day psychomotor impairment, including impaired driving if 1:
- Taken with less than 7-8 hours of sleep remaining
- Higher than recommended dose is taken
- Coadministered with CNS depressants or alcohol
- Coadministered with drugs that increase zolpidem blood levels
Monitoring Considerations
- QTc interval: In elderly patients or those with cardiac risk factors, monitor for QTc prolongation, especially if combined with other QTc-prolonging medications 4
- Residual effects: Monitor for morning drowsiness, coordination problems, and cognitive impairment 3
- Tolerance development: While uncommon with short-term use, tolerance has been reported with high doses over extended periods 3
Clinical Pearls
- Administration on an empty stomach is advised to maximize effectiveness 2
- Zolpidem should be discontinued immediately if a patient experiences a complex sleep behavior 1
- The FDA recommends lower doses (5 mg for immediate-release products and 6.25 mg for extended-release formulations) due to risk of next-morning impairment 2
- Short-term use (≤4 weeks) is recommended to minimize risk of dependence 3
- Patients should be cautioned about the importance of allowing appropriate sleep time (7-8 hours) 2, 1
By understanding these contraindications and precautions, clinicians can better assess the risk-benefit ratio of prescribing zolpidem for individual patients and minimize potential adverse outcomes.